These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12387052)

  • 1. [Perspective for development of insulin sensitizers].
    Kadowaki T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():566-72. PubMed ID: 12387052
    [No Abstract]   [Full Text] [Related]  

  • 2. [A trend of insulin sensitizer which is under development].
    Kadowaki T
    Nihon Rinsho; 2001 Nov; 59(11):2186-90. PubMed ID: 11712405
    [No Abstract]   [Full Text] [Related]  

  • 3. [PPAR gamma and thiozolidinedione derivatives as an antidiabetic drug for treating insuline resistance].
    Horikoshi H; Yachi M
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1096-101. PubMed ID: 10771679
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance and beta-cell function--a clinical perspective.
    Matthews DR
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
    [No Abstract]   [Full Text] [Related]  

  • 5. [New antidiabetic in "virtual reality". Eye to eye with insulin resistance].
    MMW Fortschr Med; 2000 May; 142(19):52. PubMed ID: 10850084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rosiglitazone (BRL-49653)].
    Oka Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
    Sugiyama Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
    Lotz N
    MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.
    Willson TM; Cobb JE; Cowan DJ; Wiethe RW; Correa ID; Prakash SR; Beck KD; Moore LB; Kliewer SA; Lehmann JM
    J Med Chem; 1996 Feb; 39(3):665-8. PubMed ID: 8576907
    [No Abstract]   [Full Text] [Related]  

  • 10. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug].
    Toyota T
    Nihon Rinsho; 2001 Nov; 59(11):2211-8. PubMed ID: 11712410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms by which PPAR gamma modulators regulate insulin sensitivity].
    Yamauchi T; Kadowaki T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():578-87. PubMed ID: 12387054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pioglitazone].
    Kobayashi M; Iwata M; Hiratani K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-cell deterioration--prospects for reversal or prevention.
    Finegood DT; Topp BG
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S20-7. PubMed ID: 11685825
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylacetic acid derivatives as hPPAR agonists.
    Santini C; Berger GD; Han W; Mosley R; MacNaul K; Berger J; Doebber T; Wu M; Moller DE; Tolman RL; Sahoo SP
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1277-80. PubMed ID: 12657263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone.
    Zinman B
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S34-43. PubMed ID: 11685828
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
    Olefsky JM
    J Clin Invest; 2000 Aug; 106(4):467-72. PubMed ID: 10953021
    [No Abstract]   [Full Text] [Related]  

  • 18. Pioglitazone: mechanism of action.
    Smith U
    Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glitazones: good for glycemia. Good for the liver?
    Isley WL
    Diabetes Technol Ther; 2003; 5(1):43-4. PubMed ID: 12725706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin sensitizer drugs--review].
    Yamanouchi T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.